Joseph Balfe: Breaking the Wall of Asthma 

Every day, the lives of more than 1000 people are cut short because of an asthma attack, and most of these deaths are preventable due to a simple delay in obtaining inhaled medications during the final attack. Because of this, we are developing a smart, wearable, bronchodilator device that can detect and rapidly intervene during asthma attacks using advanced neuromodulation technology.

Joseph is a Clinical Trials Associate at Pacific Edge Ltd., a world-leading cancer diagnostics company specialised in non-invasive genomic urine testing for bladder cancer. After completing a Bachelor of Music in Performance, Joseph pursued his science career, and recently completed a Master of Science with distinction in Neuroscience at the University of Otago. As an inventor of a patented neuromodulation device, he is committed to leveraging the therapeutic potential of neuromodulation technology to solve biomedical problems.